Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
IMNO 2023: Imaging Network Ontario Symposium
IMNO 2023: Imaging Network Ontario Symposium
Scintica will be exhibiting at IMNO 2023: Imaging Network Ontario Symposium. This year’s conference will be held at the DoubleTree Hilton in London, Ontario. Meet us at there!
About the meeting
The Imaging Network Ontario (ImNO) hosts an annual symposium that promotes collaborations, broadcasts career opportunities, informs trainees on diverse imaging applications and fosters a greater understanding of the commercialization process.
Who’s attending?
The symposium features world-renowned keynote speakers and sessions that bring together our trainees with imaging scientists, clinicians and patient groups, and industry representatives. This year we are excited to be back to an in-person meeting.
When does the meeting take place?
Thursday, March 23 – Friday, March 24
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders